New tool aims to slash months-long thyroid dose adjustment to weeks
NCT ID NCT06455371
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a decision support tool that uses blood samples from the first two weeks after thyroid surgery to predict the best levothyroxine dose. Normally, dose adjustments take months of trial and error. The trial will enroll 240 patients and compare the tool's guidance to standard care, measuring how quickly patients reach their target thyroid hormone levels and how they feel.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
decision support tool
What this could lead to
If it works, this tool could help patients reach the right thyroid hormone dose faster, reducing months of symptoms like fatigue and brain fog.
What could go wrong
This is a small, early-stage study. The tool may not speed up dose adjustment or improve patient outcomes compared to standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Haukeland University Hospital
RECRUITINGBergen, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oslo University Hospital
RECRUITINGOslo, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital of North Norway
RECRUITINGTromsø, 9010, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••